A collaborative structure supporting 
groundbreaking clinical trials

As part of the National Cancer Institute’s National Clinical Trials Network (NCTN) and a leading Research Base for the NCI Community Oncology Research Program (NCORP), the Alliance helps change standards of care, inform national treatment guidelines, and improve the lives of countless people affected by cancer.

From concept to clinical trial

An overview of how Alliance clinical trials are developed, including NCTN and AFT pathways, from concept through activation.

NCTN and AFT: Two pathways for advancing research

Alliance’s collaborative structure is designed to support rigorous, multi-site clinical trials while ensuring scientific oversight, operational efficiency, and broad participation across academic and community settings.

Alliance’s role in the National Clinical Trials Network (NCTN)

The National Clinical Trials Network (NCTN) is a program of the National Cancer Institute (NCI) that brings together leading cooperative groups, academic centers, and community oncology sites to design and conduct large, multi-site cancer clinical trials under a shared framework for scientific review, oversight, and data quality.

AFT: Industry-sponsored trials

Alliance Foundation Trials (AFT) supports industry- and foundation-sponsored studies conducted through the Alliance’s national research network. These trials are conducted independently from NCTN trials and do not receive any federal funding.